Cargando…
Impact of Treatment Supporters on the Treatment Outcomes of Drug Resistant-Tuberculosis (DR-TB) Patients: A Retrospective Cohort Study
Background: Drug resistant-tuberculosis (DR-TB) patients are provided universal drug susceptibility testing (UDST), anti-TB drugs for the treatment of DR-TB, nutritional support (Nikshay Poshan Yojana - the financial incentive of rupees five hundred per month for each notified DR-TB patient for the...
Autores principales: | Giri, Om P, Kumar, Abhay, Giri, Vishal P, Nikhil, Nishant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982631/ https://www.ncbi.nlm.nih.gov/pubmed/35399462 http://dx.doi.org/10.7759/cureus.22886 |
Ejemplares similares
-
Dual Anticoagulation in Recurrent Thromboembolic Events with Failure of Monotherapy: A Novel Approach
por: Chintalacheruvu, Lakshmi Manogna, et al.
Publicado: (2017) -
Adverse Drug Reaction Monitoring in Multidrug-Resistant Tuberculosis Patients Receiving Bedaquiline and Delamanid-Based Regimen
por: Paikray, Elisha, et al.
Publicado: (2022) -
Ivacaftor for the Treatment of Cystic Fibrosis Coexisting with Trisomy 21: A Case Report
por: Charbek, Edward, et al.
Publicado: (2019) -
Pulmonary Infection Caused by Mycobacterium terrae: A Case Report and Literature Review
por: Duran, Melanie, et al.
Publicado: (2019) -
A Different Approach to the Treatment of Tracheal Stenosis
por: Sung, Deny, et al.
Publicado: (2023)